Profiling of Serum Metabolites of Acute Intermittent Porphyria and Asymptomatic HMBS Mutation Carriers
This study aims to present the serum metabolite profiles of patients with acute intermittent porphyria (AIP) and identify specific metabolites that could potentially discriminate between AIP, asymptomatic HMBS mutation carriers, and healthy individuals. The study cohort included 46 female participan...
Main Authors: | Chia-Ni Lin, Ming-Shi Shiao, Mei-Ling Cheng, Chiung-Mei Chen, Hung-Chou Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/10/2579 |
Similar Items
-
A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort
by: Ming-Jen Lee, et al.
Published: (2024-06-01) -
Acute intermittent porphyria in a 23-year-old man: case report
by: Tarcísio Silva Borborema, et al.
Published: (2023-10-01) -
Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias
by: Andrea Ricci, et al.
Published: (2021-11-01) -
Baseline urinary ALA and PBG as criteria for starting pharmacologic prophylactic treatment in acute intermittent porphyria treated with givosiran
by: Hung-Chou Kuo, et al.
Published: (2024-12-01) -
Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications
by: Andrea Ricci, et al.
Published: (2021-12-01)